X2HQ38B
Insertion Anterior Tibial Artery, Left to New Technology Group 11 with Intraluminal Device, Temporary, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | H Insertion |
| Body Part | Q Anterior Tibial Artery, Left |
| Approach | 3 Percutaneous |
| Device | 8 Intraluminal Device, Temporary |
| Qualifier | B New Technology Group 11 |
Operation Definition
Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part
Procedure Overview
This family covers implanting a nonbiological device into the heart or a blood vessel that monitors or supports a physiological function without replacing any tissue itself. A common example is a leadless cardiac pacemaker, a self-contained capsule placed directly inside a heart chamber through a catheter rather than through a surgically implanted pulse generator with wire leads. The device senses the heart's electrical activity and delivers pacing impulses as needed, addressing slow or irregular heart rhythms.
Because the New Technology section exists to track devices recently approved for distinct reimbursement and outcomes monitoring, these procedures are typically newer catheter-based alternatives to long-established open or lead-based techniques. Patients considering them are often candidates who face higher risk from traditional lead placement, such as those with prior infections or difficult venous access.
Anatomy & Axis Detail
Anterior Tibial Artery, Left
The left anterior tibial artery supplies the anterior compartment of the left lower leg and foot in the same manner as its right-sided counterpart, and it becomes a relevant site for device insertion primarily in the context of localized arterial disease affecting that limb. Its narrow diameter and location deep to the extensor muscles of the leg mean that access is usually achieved with fine catheter techniques under imaging guidance rather than direct surgical exposure. Because peripheral arterial disease often affects the two legs asymmetrically, the left side may show a different pattern of stenosis or occlusion than the right, which is why laterality is recorded precisely. Devices placed here are typically tied to treatment or monitoring of blood flow to the distal leg and foot.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Intraluminal Device, Temporary
This value denotes an intraluminal device intended for short-term placement within a body lumen, later removed once its therapeutic purpose has been served. It is distinguished from expandable, covered, or bioprosthetic intraluminal devices that are generally left in place permanently. Temporary devices are chosen when transient support, drainage, or protection of the lumen is the clinical goal.
Qualifier: New Technology Group 11
This qualifier designates Group 11, the most recent cohort at the time of its introduction, grouping technologies newly approved for New Technology section reporting in that fiscal year. Like every group value in this axis, it functions as an administrative marker rather than a description of the clinical intervention, which is captured elsewhere in the code. Its main point of confusion is with Group 10, the immediately preceding annual release.
Coding & Documentation
Coders need the operative note to confirm the specific brand or device named in the New Technology table entry, since these codes are device-specific rather than generic. Documentation should state the approach (typically percutaneous), the target chamber, and confirmation that the device itself performs the monitoring or assistive function rather than serving as a structural replacement. A frequent error is defaulting to the standard Cardiovascular section code for pacemaker or device insertion instead of checking whether the specific model qualifies for a New Technology designation, which can materially change reimbursement. Another common miss is failing to update code selection when a device's New Technology group value changes between annual code set updates.
Commonly Confused With
This is easily confused with standard Insertion procedures coded in the regular Cardiovascular System section, where the distinguishing factor is solely whether the device brand appears in the New Technology reference table for that year. It is also distinct from Replacement, which applies when the device or material takes over the physical role of a body part rather than simply monitoring or assisting it.